{
    "success": true,
    "data": {
        "ucits": false,
        "type": "ETP",
        "leverage": true,
        "derivatives": true,
        "swaps": true,
        "inverse": true,
        "complex_factors": [
            "Leverage",
            "Inverse exposure",
            "Daily rebalancing",
            "Compounding effect",
            "Lack of capital protection",
            "High risk rating (Class 6/7)"
        ],
        "replication_method": "synthetic",
        "classification": "complex",
        "supporting_data": "The ETP Securities aim to provide -1 times the daily performance of The Walt Disney Company equity security, which inherently involves leverage and inverse exposure. The Key Investor Information Document explicitly warns about the 'Compounding Effect' due to daily leverage rebalancing, stating that holding the product for more than one day is likely to result in a return different from the target and that this effect is magnified with longer holding periods and higher volatility. The product is classified as Class 6 out of 7 on the risk indicator, indicating a high level of risk. Furthermore, the KID states that the product has no capital protection and that investors may lose some or all of their investment. The product's structure relies on tracking an index that uses inverse leverage, implying the use of derivatives like total return swaps to achieve its objective. The fact that it is an ETP (Exchange Traded Product) and not an ETF (Exchange Traded Fund) often implies a different, potentially more complex, structural mechanism, often involving OTC derivatives and collateral arrangements. The 'comprehension alert' explicitly states: 'You are about to purchase a product that is not simple and may be difficult to understand', which is a direct indicator of complexity under MiFID II. The product's objective is to provide an inverse leveraged return, which is a derivative strategy and therefore generally considered complex. MiFID II guidelines (Article 25(4) of MiFID II and Article 57 of the MiFID II Delegated Regulation) and ESMA guidance indicate that products with leverage and inverse exposure, especially those with daily rebalancing and compounding effects, are typically classified as complex because their structure and risks are not easily understood by retail investors. The use of swaps for replication is central to achieving the inverse leveraged objective, and the associated counterparty and collateral risks (even if not explicitly detailed in this excerpt, they are inherent in synthetic replication) contribute to complexity. ESMA guidelines, particularly referencing the difficulty for retail investors to understand the risks of compounded returns and inverse leveraged products, reinforce this classification."
    }
}